Dubreuil J - Search Results

1

18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.

Dubreuil J, Giammarile F, Rousset P, Rubello D, Colletti PM, Glehen O, Skanjeti A. Dubreuil J, et al. Nucl Med Commun. 2017 Jan;38(1):1-9. doi: 10.1097/MNM.0000000000000613. Nucl Med Commun. 2017. PMID: 27820721 Review.

2

FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma.

Dubreuil J, Moreau A, Sarkozy C, Traverse-Glehen A, Skanjeti A, Salles G, Giammarile F. Dubreuil J, et al. Clin Nucl Med. 2016 May;41(5):397-8. doi: 10.1097/RLU.0000000000001111. Clin Nucl Med. 2016. PMID: 26825213

3

FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.

Dubreuil J, Giammarile F, Rousset P, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A. Dubreuil J, et al. Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1630-7. doi: 10.1007/s00259-016-3347-z. Epub 2016 Feb 24. Eur J Nucl Med Mol Imaging. 2016. PMID: 26907364 Clinical Trial.

4

Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.

Dubreuil J, Tordo J, Rubello D, Giammarile F, Skanjeti A. Dubreuil J, et al. Nucl Med Commun. 2017 Jan;38(1):84-90. doi: 10.1097/MNM.0000000000000612. Nucl Med Commun. 2017. PMID: 27898647 Review.

5

Diffuse Subcutaneous Fat Involvement in a Marginal Zone Lymphoma.

Dubreuil J, Noel R, Tordo J, Salles G, Skanjeti A. Dubreuil J, et al. Clin Nucl Med. 2017 Feb;42(2):129-130. doi: 10.1097/RLU.0000000000001467. Clin Nucl Med. 2017. PMID: 27941375

6

Cat-Scratch Disease: A Pitfall for Lymphoma Evaluation by FDG-PET/CT.

Dubreuil J, Dony A, Salles G, Traverse-Glehen A, Giammarile F, Skanjeti A. Dubreuil J, et al. Clin Nucl Med. 2017 Feb;42(2):106-107. doi: 10.1097/RLU.0000000000001492. Clin Nucl Med. 2017. PMID: 27997427

7

The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma.

Dubreuil J, Giammarile F, Rousset P, Rubello D, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A. Dubreuil J, et al. Nucl Med Commun. 2017 Apr;38(4):312-318. doi: 10.1097/MNM.0000000000000649. Nucl Med Commun. 2017. PMID: 28244976

8

Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review.

Dubreuil J, Salles G, Bozzetto J, Tordo J, Djaïleb L, Berriolo-Riedinger A, Leenhardt J, Giammarile F, Meignan M, Skanjeti A. Dubreuil J, et al. Nucl Med Commun. 2017 Jul;38(7):563-576. doi: 10.1097/MNM.0000000000000697. Nucl Med Commun. 2017. PMID: 28570287 Free article. Review.

9

EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, Audisio RA, Zoras O, Lassmann M, Chakera AH, Uren R, Chondrogiannis S, Colletti PM, Rubello D. Bluemel C, et al. Among authors: dubreuil j. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1750-1766. doi: 10.1007/s00259-015-3135-1. Epub 2015 Jul 25. Eur J Nucl Med Mol Imaging. 2015. PMID: 26205952

10

Erratum to: FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.

Dubreuil J, Giammarile F, Rousset P, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A. Dubreuil J, et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1570. doi: 10.1007/s00259-016-3387-4. Eur J Nucl Med Mol Imaging. 2016. PMID: 27044382 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page